Hallandale Semaglutide vs Tirzepatide: What Patients Should Know

Published September 4, 2026

Last verified: August 28, 2026

Quick answer

Hallandale Pharmacy currently lists both compounded semaglutide and compounded tirzepatide injectable products.

Semaglutide acts primarily at the GLP-1 receptor. Tirzepatide has dual GIP and GLP-1 receptor activity. They are different prescription drugs with different dosing and clinical considerations.

Hallandale's current public catalog lists:

semaglutide at 2.5 mg/mL and 5 mg/mL;
tirzepatide at 10 mg/mL and 15 mg/mL.

The concentrations are not interchangeable, and syringe units should never be converted from one drug to the other without prescription-specific instructions.

Hallandale formulations at a glance

Medication	Current Hallandale public concentrations
Compounded semaglutide	2.5 mg/mL and 5 mg/mL
Compounded tirzepatide	10 mg/mL and 15 mg/mL

Both are compounded products and are not FDA-approved finished drug products.

How semaglutide and tirzepatide differ

Semaglutide

Semaglutide is a GLP-1 receptor agonist.

There are FDA-approved branded semaglutide products, but compounded semaglutide is not one of them and is not an FDA-approved finished drug product.

Tirzepatide

Tirzepatide targets both GIP and GLP-1 receptors.

There are FDA-approved branded tirzepatide products. Compounded tirzepatide is not a generic equivalent of any of them and is not an FDA-approved finished drug product.

Is tirzepatide just "stronger semaglutide"?

No.

That framing is too simplistic.

They are different molecules with different receptor activity, dosing schedules, contraindications and clinical evidence.

A clinician may prefer one or the other based on:

medical history;
prior treatment;
side effects;
contraindications;
treatment goals;
access to approved products;
individualized reason for compounding.

Can I compare syringe units?

No.

A syringe unit measures liquid volume.

The actual drug dose depends on:

concentration × volume = milligram dose

Because Hallandale lists multiple concentrations, the same number of syringe units can represent a different dose depending on the vial.

Never copy a dosing chart from another patient.

Which produces more weight loss?

Clinical trials of FDA-approved branded semaglutide and tirzepatide can inform clinicians about the active ingredients, but it is not appropriate to promise that a compounded product will reproduce the exact results of an FDA-approved product trial.

Individual outcomes vary.

The clinically relevant question is not simply "which loses more weight?" but which treatment is appropriate for the patient's medical history and goals.

Can I switch from Hallandale semaglutide to Hallandale tirzepatide?

Only through a clinician's treatment decision and new prescription.

There is no consumer conversion formula such as:

X units semaglutide = Y units tirzepatide.

If switching, the clinician should establish the new dose.

Are either of Hallandale's compounded GLP-1 drugs FDA approved?

No.

FDA states that compounded drugs are not FDA approved.

That is why Ozari's own Pharmacy Standards page explicitly says compounded semaglutide and tirzepatide are not therapeutically equivalent to the FDA-approved branded finished products.

What does 503A status mean here?

Hallandale is a 503A compounding pharmacy.

503A compounding is built around patient-specific prescriptions and applicable federal conditions.

The existence of a Hallandale product catalog does not mean any consumer can simply order a GLP-1 without clinical review and a valid prescription.

How Ozari Health works with Hallandale Pharmacy

Ozari Health publicly identifies Hallandale Pharmacy as one of its two state-licensed 503A compounding pharmacy partners, alongside VialsRx. Ozari says every prescription is patient-specific, written by a licensed prescriber, and routed according to the patient's state, medication and dose, and current pharmacy capacity.

Patients do not select the dispensing pharmacy by request. The prescription label identifies which pharmacy prepared the medication.

That disclosure creates an important distinction for patients researching GLP-1 telehealth companies: Ozari does not describe fulfillment only as coming from an unnamed "partner pharmacy." Patients can independently research Hallandale's facility, credentials, public FDA history, product catalog, and contact information.

How Ozari approaches semaglutide vs tirzepatide

Ozari publishes separate semaglutide and tirzepatide treatment programs.

A licensed clinician makes the prescribing decision. If compounded treatment is appropriate for the patient's documented individual need, the prescription can be prepared by Hallandale or VialsRx according to state, medication/dose and capacity.

Frequently asked questions

Does Hallandale make both semaglutide and tirzepatide?

Yes.

What concentration is Hallandale semaglutide?

Hallandale currently lists 2.5 mg/mL and 5 mg/mL.

What concentration is Hallandale tirzepatide?

Hallandale currently lists 10 mg/mL and 15 mg/mL.

Is tirzepatide just a stronger version of semaglutide?

No. They are different drugs.

Can I convert syringe units between them?

No. Dosing must be based on the specific drug, concentration and prescription.

Does Ozari use Hallandale for both GLP-1s?

Ozari identifies Hallandale as a pharmacy partner for patient-specific compounded GLP-1 prescriptions. Actual routing depends on the individual prescription and logistics.

Medical and regulatory disclaimer

This article is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved finished drug products and are not reviewed by FDA for safety, effectiveness, or quality before marketing in the same way as FDA-approved drugs. A licensed clinician must determine whether a compounded medication is appropriate for an individual patient and whether the prescription meets applicable federal and state requirements.

Pharmacy availability, formulations, prices, state coverage, provider relationships, credentials, and regulatory records can change. Verify current information before making a treatment decision.

Sources

Explore Ozari's pharmacy standards

Ozari Health publicly names the pharmacies that prepare eligible patient-specific compounded GLP-1 prescriptions.

general